KMTS - CIK 0001877184
The table below shows KESTRA MEDICAL TECHNOLOGIES, LTD.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 |
|---|---|---|
| Operating cash flow | -$26.27M | -$17.50M |
| Capital expenditure | $8.17M | $7.04M |
| Investing cash flow | -$8.23M | -$7.03M |
| Dividends paid | - | - |
| Stock buybacks | - | - |
| Financing cash flow | -$1.88M | $116.25M |
KESTRA MEDICAL TECHNOLOGIES, LTD. reported operating cash flow of -$77.61M for fiscal year 2025. That is down 7.4% from -$72.23M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.